LGND
Price
$302.96
Change
+$0.22 (+0.07%)
Updated
Oct 2 closing price
Capitalization
6.26B
33 days until earnings call
Intraday BUY SELL Signals
TVTX
Price
$56.93
Change
+$0.08 (+0.14%)
Updated
Oct 2 closing price
Capitalization
5.8B
19 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LGND vs TVTX

LGND vs TVTX Comparison Chart in %
View a ticker or compare two or three
VS
LGND vs. TVTX commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGND is a Buy and TVTX is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
LGND vs TVTX: Fundamental Ratings
LGND
TVTX
OUTLOOK RATING
1..100
2378
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
96
Overvalued
PROFIT vs RISK RATING
1..100
535
SMR RATING
1..100
4499
PRICE GROWTH RATING
1..100
3937
P/E GROWTH RATING
1..100
9732
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LGND's Valuation (81) in the Biotechnology industry is in the same range as TVTX (96). This means that LGND’s stock grew similarly to TVTX’s over the last 12 months.

LGND's Profit vs Risk Rating (5) in the Biotechnology industry is in the same range as TVTX (35). This means that LGND’s stock grew similarly to TVTX’s over the last 12 months.

LGND's SMR Rating (44) in the Biotechnology industry is somewhat better than the same rating for TVTX (99). This means that LGND’s stock grew somewhat faster than TVTX’s over the last 12 months.

TVTX's Price Growth Rating (37) in the Biotechnology industry is in the same range as LGND (39). This means that TVTX’s stock grew similarly to LGND’s over the last 12 months.

TVTX's P/E Growth Rating (32) in the Biotechnology industry is somewhat better than the same rating for LGND (97). This means that TVTX’s stock grew somewhat faster than LGND’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LGNDTVTX
RSI
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 16 days ago
79%
Declines
ODDS (%)
Bearish Trend 17 days ago
69%
Bearish Trend 2 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
74%
Aroon
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
87%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (LGND: $302.96 vs. TVTX: $56.93)
Brand notoriety: LGND and TVTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LGND: 75% vs. TVTX: 71%
Market capitalization -- LGND: $6.26B vs. TVTX: $5.8B
LGND [@Biotechnology] is valued at $6.26B. TVTX’s [@Biotechnology] market capitalization is $5.8B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LGND’s FA Score shows that 1 FA rating(s) are green while TVTX’s FA Score has 1 green FA rating(s).

  • LGND’s FA Score: 1 green, 4 red.
  • TVTX’s FA Score: 1 green, 4 red.
According to our system of comparison, both LGND and TVTX are a good buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LGND’s TA Score shows that 5 TA indicator(s) are bullish while TVTX’s TA Score has 4 bullish TA indicator(s).

  • LGND’s TA Score: 5 bullish, 5 bearish.
  • TVTX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, LGND is a better buy in the short-term than TVTX.

Price Growth

LGND (@Biotechnology) experienced а +0.48% price change this week, while TVTX (@Biotechnology) price change was -4.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.69%. For the same industry, the average monthly price growth was -14.41%, and the average quarterly price growth was -1.73%.

Reported Earning Dates

LGND is expected to report earnings on Nov 05, 2026.

TVTX is expected to report earnings on Oct 22, 2026.

Industries' Descriptions

@Biotechnology (-3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
LGND
Daily Signal:
Gain/Loss:
TVTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HODU13.360.36
+2.77%
Direxion Daily HOOD Bull 2X ETF (HODU)
YNOT34.270.55
+1.63%
Horizon Digital Frontier ETF (YNOT)
FENI40.000.44
+1.11%
Fidelity Enhanced International ETF (FENI)
EASY25.760.06
+0.23%
Liberty One Defensive Dividend Growth ETF (EASY)
IEO136.600.20
+0.15%
iShares U.S. Oil & Gas Exploration & Production ETF (IEO)